Schedule 13G ownership disclosure
InMed Pharmaceuticals Inc.
Security class unavailable · CUSIP: 457637502
Event date: 2020-11-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 444,444
- Percent of class
- 6.3500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-20-004010
- Form type
- SC 13G
- Filer
- Empery Asset Management, LP
- CIK
- CIK 1469336
- Filed
- Nov 18, 2020
- Reporting period
- Nov 12, 2020
- Description
- Schedule 13G beneficial ownership